Cover Image
Market Research Report
Product code 
1067091

Acute Sinusitis Market Research Report- Forecast till 2027

Published: | Market Research Future | 126 Pages | Delivery time: 1-2 business days

Price

Back to Top
Acute Sinusitis Market Research Report- Forecast till 2027
Published: March 22, 2022
Market Research Future
Content info: 126 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Market Overview

Acute Sinusitis Market is anticipated to register a significant CAGR of 7.89% during the study period to surpass a market value of USD 3,319.41 million by 2027. Sinusitis is an irritation, or expanding, of the tissue covering the sinuses. This article depicts those in danger, signs and side effects, conclusion, and medicines. The side effects of sinusitis are like those of colds and nasal sensitivities, which makes the analysis troublesome. The global market growth attributed to the developing number of individuals experiencing intense sinusitis, as well as the broad scope of therapy and symptomatic choices accessible. Besides, the market's advancement is hampered by an absence of mindfulness about intense sinusitis. Additionally, the Expanded worldwide R&D and medical care spending, then again, is relied upon to give development possibilities to worldwide market pioneers.

The global acute sinusitis market is anticipated to witness a healthy market development during the forecast period due to the rising population of patients suffering from acute sinusitis worldwide. As per the research sinusitis is second most common disease. Furthermore, the availability of several treatment and diagnostic options for acute sinusitis propels the further acute sinusitis market during the review period. However, the lack of understanding of acute sinusitis may restrain the market growth in future. The worldwide acute sinusitis market is developing at a critical rate because of the rising number of players approaching to give items and administrations and the rising number of patients experiencing intense sinusitis.

Market Segmentation

The global acute sinusitis market has been classified based on Diagnosis and treatment, end-user, and others.

In terms of diagnosis and treatment the market is bifurcated into diagnosis and treatment. The diagnosis segment is further classified into laboratory test, allergy testing, nasal endoscopy, and imaging test. By, treatment type, the market is sub-divided into saline nasal spray, nasal corticosteroids, decongestants pain relievers, allergy shots, antibiotics. The end-user section is segregated among Hospitals, and clinics, research centres and others. The others segment is further categorized as diagnostic laboratories, radiography centers, and dedicated endoscopy centers.

Regional Market

Americas is likely to drive the largest market for acute sinusitis owing to the the rising number of acute sinusitis patients and the existanc of established players in the region. Europe held the second biggest piece of the pie in 2020. This is because of rising pervasiveness of sinusitis and the rising geriatric populace. Besides, expanding drives by the public authority in the district for consciousness of sinusitis is additionally impacting the market development. Expanding medical services consumption and exploration subsidizing combined with the rising number of clinical preliminaries has additionally helped the market development. Asia-Pacific market for acte sinusitis is attributed to the further developing medical care framework and expanding number of patients experiencing acute sinusitis, are expected to drive the market development in the region.

Major Players

The key players of the global acute sinusitis market are Sanofi (France), Abbott (US), Bayer AG (Germany), Aurobindo Pharma (India), Bristol Myers Squibb (US), Merck KGaA (Germany), AstraZeneca (UK), Reddy's Laboratories, Ltd. (India), Novartis AG (Switzerland), and GlaxoSmithKline plc (UK).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

Product Code: MRFR/HC/4371-CR

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
    • 3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
    • 3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.4 FORECASTING TECHNIQUES
  • 3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.5.1 BOTTOM-UP APPROACH
    • 3.5.2 TOP-DOWN APPROACH
  • 3.6 DATA TRIANGULATION
  • 3.7 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING NUMBER OF PATIENTS SUFFERING FROM ACUTE SINUSITIS
    • 4.2.2 AVAILABILITY OF SEVERAL TREATMENT AND DIAGNOSTIC OPTIONS
  • 4.3 RESTRAINTS
    • 4.3.1 LACK OF AWARENESS RELATED TO ACUTE SINUSITIS
  • 4.4 OPPORTUNITIES
    • 4.4.1 RISING GLOBAL R&D INITIATIVES AND HEALTHCARE EXPENDITURE

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION & SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 THREAT OF NEW ENTRANTS
    • 5.2.2 BARGAINING POWER OF SUPPLIERS
    • 5.2.3 THREAT OF SUBSTITUTES
    • 5.2.4 BARGAINING POWER OF BUYERS
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL ACUTE SINUSITIS MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON PATIENTS SUFFERING FROM ACUTE SINUSITIS
    • 5.3.3 IMPACT ON DEMAND AND SUPPLY
    • 5.3.4 IMPACT ON TECHNOLOGY

6 GLOBAL ACUTE SINUSITIS MARKET, BY DIAGNOSIS &TREATMENT

  • 6.1 INTRODUCTION
  • 6.2 BY DIAGNOSIS
    • 6.2.1 NASAL ENDOSCOPY
    • 6.2.2 IMAGING TEST
    • 6.2.3 LABORATORY TEST
    • 6.2.4 ALLERGY TESTING
  • 6.3 BY TREATMENT
    • 6.3.1 SALINE NASAL SPRAY
    • 6.3.2 NASAL CORTICOSTEROIDS
    • 6.3.3 DECONGESTANTS
    • 6.3.4 OTC PAIN RELIEVERS
    • 6.3.5 ALLERGY SHOTS
    • 6.3.6 ANTIBIOTICS

7 GLOBAL ACUTE SINUSITIS MARKET, BY END USER

  • 7.1 INTRODUCTION
  • 7.2 HOSPITALS & CLINICS
  • 7.3 RESEARCH CENTERS
  • 7.4 OTHERS

8 GLOBAL ACUTE SINUSITIS MARKET, BY REGION

  • 8.1 OVERVIEW
  • 8.2 AMERICAS
    • 8.2.1 NORTH AMERICA
      • 8.2.1.1 US
      • 8.2.1.2 CANADA
    • 8.2.2 SOUTH AMERICA
  • 8.3 EUROPE
    • 8.3.1 WESTERN EUROPE
      • 8.3.1.1 GERMANY
      • 8.3.1.2 FRANCE
      • 8.3.1.3 UK
      • 8.3.1.4 ITALY
      • 8.3.1.5 SPAIN
      • 8.3.1.6 REST OF WESTERN EUROPE
    • 8.3.2 EASTERN EUROPE
  • 8.4 ASIA-PACIFIC
    • 8.4.1 CHINA
    • 8.4.2 INDIA
    • 8.4.3 JAPAN
    • 8.4.4 REPUBLIC OF KOREA
    • 8.4.5 AUSTRALIA
    • 8.4.6 REST OF ASIA PACIFIC
  • 8.5 MIDDLE EAST & AFRICA
    • 8.5.1 SAUDI ARABIA
    • 8.5.2 UNITED ARAB EMIRATES
    • 8.5.3 OMAN
    • 8.5.4 KUWAIT
    • 8.5.5 QATAR
    • 8.5.6 REST OF THE MIDDLE EAST & AFRICA

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 COMPETITIVE BENCHMARKING
  • 9.3 MAJOR GROWTH STRATEGY IN THE GLOBAL ACUTE SINUSITIS MARKET
  • 9.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL ACUTE SINUSITIS MARKET
  • 9.5 KEY DEVELOPMENT ANALYSIS
  • 9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 9.6.1 PRODUCT LAUNCHES/PRODUCT APPROVALS
    • 9.6.2 MERGERS & ACQUISITIONS
  • 9.7 FINANCIAL MATRIX
    • 9.7.1 SALES (USD MILLION), 2020
    • 9.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2020

10 COMPANY PROFILES

  • 10.1 SANOFI
    • 10.1.1 COMPANY OVERVIEW
    • 10.1.2 FINANCIAL OVERVIEW
    • 10.1.3 PRODUCTS/SERVICES OFFERED
    • 10.1.4 KEY DEVELOPMENTS
    • 10.1.5 SWOT ANALYSIS
    • 10.1.6 KEY STRATEGIES
  • 10.2 ABBOTT
    • 10.2.1 COMPANY OVERVIEW
    • 10.2.2 FINANCIAL OVERVIEW
    • 10.2.3 PRODUCTS/SERVICES OFFERED
    • 10.2.4 KEY DEVELOPMENTS
    • 10.2.5 SWOT ANALYSIS
    • 10.2.6 KEY STRATEGIES
  • 10.3 BAYER AG
    • 10.3.1 COMPANY OVERVIEWS
    • 10.3.2 FINANCIAL OVERVIEW
    • 10.3.3 PRODUCTS/SERVICES OFFERED
    • 10.3.4 KEY DEVELOPMENTS
    • 10.3.5 SWOT ANALYSIS
    • 10.3.6 KEY STRATEGIES
  • 10.4 AUROBINDO PHARMA
    • 10.4.1 COMPANY OVERVIEW
    • 10.4.2 FINANCIAL OVERVIEW
    • 10.4.3 PRODUCTS/SERVICES OFFERED
    • 10.4.4 KEY DEVELOPMENTS
    • 10.4.5 SWOT ANALYSIS
    • 10.4.6 KEY STRATEGIES
  • 10.5 BRISTOL-MYERS SQUIBB
    • 10.5.1 COMPANY OVERVIEW
    • 10.5.2 FINANCIAL OVERVIEW
    • 10.5.3 PRODUCTS/SERVICES OFFERED
    • 10.5.4 KEY DEVELOPMENTS
    • 10.5.5 SWOT ANALYSIS
    • 10.5.6 KEY STRATEGIES
  • 10.6 MERCK KGAA
    • 10.6.1 COMPANY OVERVIEW
    • 10.6.2 FINANCIAL OVERVIEW
    • 10.6.3 PRODUCTS OFFERED
    • 10.6.4 KEY DEVELOPMENTS
    • 10.6.5 SWOT ANALYSIS
    • 10.6.6 KEY STRATEGIES
  • 10.7 ASTRAZENECA
    • 10.7.1 COMPANY OVERVIEW
    • 10.7.2 FINANCIAL OVERVIEW
    • 10.7.3 PRODUCTS/SERVICES OFFERED
    • 10.7.4 KEY DEVELOPMENTS
    • 10.7.5 SWOT ANALYSIS
    • 10.7.6 KEY STRATEGIES
  • 10.8 DR. REDDY'S LABORATORIES LTD
    • 10.8.1 COMPANY OVERVIEW
    • 10.8.2 FINANCIAL OVERVIEW
    • 10.8.3 PRODUCTS/SERVICES OFFERED
    • 10.8.4 KEY DEVELOPMENTS
    • 10.8.5 SWOT ANALYSIS
    • 10.8.6 KEY STRATEGIES
  • 10.9 NOVARTIS AG
    • 10.9.1 COMPANY OVERVIEW
    • 10.9.2 FINANCIAL OVERVIEW
    • 10.9.3 PRODUCTS OFFERED
    • 10.9.4 KEY DEVELOPMENTS
    • 10.9.5 SWOT ANALYSIS
    • 10.9.6 KEY STRATEGIES
  • 10.10 GLAXOSMITHKLINE PLC
    • 10.10.1 COMPANY OVERVIEW
    • 10.10.2 FINANCIAL OVERVIEW
    • 10.10.3 PRODUCTS/SERVICES OFFERED
    • 10.10.4 KEY DEVELOPMENTS
    • 10.10.5 SWOT ANALYSIS
    • 10.10.6 KEY STRATEGIES

11 APPENDIX

  • 11.1 REFERENCES
  • 11.2 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 3 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL: ACUTE SINUSITIS MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL: ACUTE SINUSITIS MARKET, FOR DIAGNOSIS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL: ACUTE SINUSITIS MARKET, FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL: ACUTE SINUSITIS MARKET, FOR NASAL ENDOSCOPY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL: ACUTE SINUSITIS MARKET, FOR IMAGING TEST, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL: ACUTE SINUSITIS MARKET, FOR LABORATORY TEST, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL: ACUTE SINUSITIS MARKET, FOR ALLERGY TESTING, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL: ACUTE SINUSITIS MARKET, FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL: ACUTE SINUSITIS MARKET, FOR TREATMENT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL: ACUTE SINUSITIS MARKET, FOR SALINE NASAL SPRAY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL: ACUTE SINUSITIS MARKET, FOR NASAL CORTICOSTEROIDS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL: ACUTE SINUSITIS MARKET, FOR DECONGESTANTS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL: ACUTE SINUSITIS MARKET, FOR OTC PAIN RELIEVERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL: ACUTE SINUSITIS MARKET, FOR ALLERGY SHOTS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 GLOBAL: ACUTE SINUSITIS MARKET, FOR ANTIBIOTICS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 19 GLOBAL: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 20 GLOBAL: ACUTE SINUSITIS MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 21 GLOBAL: ACUTE SINUSITIS MARKET, FOR RESEARCH CENTERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 22 GLOBAL: ACUTE SINUSITIS MARKET, FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 23 GLOBAL: ACUTE SINUSITIS MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 24 AMERICAS: ACUTE SINUSITIS MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 25 AMERICAS: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 26 AMERICAS: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 27 AMERICAS: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 28 AMERICAS: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 29 NORTH AMERICA: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 30 NORTH AMERICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 31 NORTH AMERICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 33 NORTH AMERICA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 34 US: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 35 US: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, TYPE, 2018-2027 (USD MILLION)
  • TABLE 36 US: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 37 US: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 38 CANADA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 39 CANADA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 40 CANADA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 41 CANADA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 42 SOUTH AMERICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 43 SOUTH AMERICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 44 SOUTH AMERICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 SOUTH AMERICA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 46 EUROPE: ACUTE SINUSITIS MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 47 EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 48 EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, TYPE, 2018-2027 (USD MILLION)
  • TABLE 49 EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 51 WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 52 WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 53 WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 54 WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 55 WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 56 GERMANY: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 57 GERMANY: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 58 GERMANY: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 59 GERMANY: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 60 FRANCE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 61 FRANCE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 62 FRANCE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 63 FRANCE: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 64 UK: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 65 UK: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 66 UK: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 UK: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 68 ITALY: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 69 ITALY: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 ITALY: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 ITALY: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 72 SPAIN: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 73 SPAIN: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 74 SPAIN: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 75 SPAIN: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 76 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 77 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 78 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 79 REST OF WESTERN EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 80 EASTERN EUROPE: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT 2018-2027 (USD MILLION)
  • TABLE 81 EASTERN EUROPE: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 82 EASTERN EUROPE: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 83 EASTERN EUROPE: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 86 ASIA-PACIFIC: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 87 ASIA-PACIFIC: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 88 ASIA-PACIFIC: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 89 CHINA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 90 CHINA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 91 CHINA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 92 CHINA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 93 INDIA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 94 INDIA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 95 INDIA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 96 INDIA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 97 JAPAN: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 98 JAPAN: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 99 JAPAN: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 100 JAPAN: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 101 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 102 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 103 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 104 REPUBLIC OF KOREA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 105 AUSTRALIA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 106 AUSTRALIA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 107 AUSTRALIA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 108 AUSTRALIA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 109 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 110 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 111 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 112 REST OF ASIA PACIFIC: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 113 MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 114 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 115 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 116 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 117 MIDDLE EAST AND AFRICA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 118 SAUDI ARABIA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 119 SAUDI ARABIA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 120 SAUDI ARABIA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 121 SAUDI ARABIA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 122 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 123 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 124 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 125 UNITED ARAB EMIRATES: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 126 OMAN: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 127 OMAN: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 128 OMAN: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 129 OMAN: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 130 KUWAIT: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 131 KUWAIT: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 132 KUWAIT: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 133 KUWAIT: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 134 QATAR: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 135 QATAR: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 136 QATAR: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 137 QATAR: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 138 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 139 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET FOR DIAGNOSIS, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 140 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET FOR TREATMENT, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 141 REST OF THE MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 142 MAJOR PLAYERS IN THE GLOBAL ACUTE SINUSITIS MARKET
  • TABLE 143 MOST ACTIVE PLAYER IN THE GLOBAL ACUTE SINUSITIS MARKET
  • TABLE 144 PRODUCT LAUNCH/PRODUCT APPROVALS
  • TABLE 145 MERGERS & ACQUISITIONS
  • TABLE 146 SANOFI: PRODUCTS/SERVICES OFFERED
  • TABLE 147 ABBOTT: PRODUCTS /SERVICES OFFERED
  • TABLE 148 BAYER AG: PRODUCTS/SERVICES OFFERED
  • TABLE 149 AUROBINDO PHARMA: PRODUCTS/SERVICES OFFERED
  • TABLE 150 BRISTOL MYERS SQUIBB: PRODUCTS/SERVICES OFFERED
  • TABLE 151 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 152 ASTRAZENECA: PRODUCTS/SERVICES OFFERED
  • TABLE 153 DR. REDDY'S LABORATORIES LTD: PRODUCTS/SERVICES OFFERED
  • TABLE 154 DR. REDDY'S LABORATORIES LTD: KEY DEVELOPMENTS
  • TABLE 155 NOVARTIS AG: PRODUCTS OFFERED
  • TABLE 156 NOVARTIS AG: KEY DEVELOPMENTS
  • TABLE 157 GLAXOSMITH KLINE PLC: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL ACUTE SINUSITIS MARKET STRUCTURE
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL ACUTE SINUSITIS MARKET
  • FIGURE 5 DRIVERS IMPACT ANALYSIS
  • FIGURE 6 RESTRAINTS IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL ACUTE SINUSITIS MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL ACUTE SINUSITIS MARKET
  • FIGURE 9 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS & TREATMENT, 2020 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL: ACUTE SINUSITIS MARKET, BY DIAGNOSIS, 2020 & 2027 (USD MILLION)
  • FIGURE 11 GLOBAL: ACUTE SINUSITIS MARKET, BY TREATMENT, 2020 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL: ACUTE SINUSITIS MARKET, BY END USER, 2020 & 2027 (USD MILLION)
  • FIGURE 13 GLOBAL: ACUTE SINUSITIS MARKET, BY REGION 2020 & 2027 (USD MILLION)
  • FIGURE 14 GLOBAL: ACUTE SINUSITIS MARKET SHARE (%), BY REGION, 2020
  • FIGURE 15 AMERICAS: ACUTE SINUSITIS MARKET SHARE (%), BY REGION 2020
  • FIGURE 16 NORTH AMERICA: ACUTE SINUSITIS MARKET SHARE (%) BY COUNTRY 2020
  • FIGURE 17 EUROPE: ACUTE SINUSITIS MARKET SHARE (%), BY REGION, 2020
  • FIGURE 18 WESTERN EUROPE: ACUTE SINUSITIS MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 19 ASIA PACIFIC: ACUTE SINUSITIS MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 20 MIDDLE EAST & AFRICA: ACUTE SINUSITIS MARKET SHARE (%), BY COUNTRY, 2020
  • FIGURE 21 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 22 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL ACUTE SINUSITIS MARKET
  • FIGURE 23 GLOBAL ACUTE SINUSITIS MARKET: COMPETITIVE LANDSCAPE
  • FIGURE 24 SALES 2020
  • FIGURE 25 RESEARCH & DEVELOPMENT EXPENDITURE, 2020
  • FIGURE 26 SANOFI: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 27 SANOFI: SWOT ANALYSIS
  • FIGURE 28 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 29 ABBOTT: SWOT ANALYSIS
  • FIGURE 30 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 31 BAYER AG: SWOT ANALYSIS
  • FIGURE 32 AUROBINDO PHARMA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 33 AUROBINDO PHARMA: SWOT ANALYSIS
  • FIGURE 34 AUROBINDO PHARMA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 35 BRISTOL MYERS SQUIBB: SWOT ANALYSIS
  • FIGURE 36 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 37 MERCK KGAA: SWOT ANALYSIS
  • FIGURE 38 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 39 ASTRAZENECA: SWOT ANALYSIS
  • FIGURE 40 DR. REDDY'S LABORATORIES LTD: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 41 DR. REDDY'S LABORATORIES LTD: SWOT ANALYSIS
  • FIGURE 42 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 43 NOVARTIS AG: SWOT ANALYSIS
  • FIGURE 44 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 45 GLAXOSMITHKLINE PLC: SWOT ANALYSIS